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Introduction
This article summarizes briefly available scientific information on the role of biopersistence in the pathogenicity of manmade fibers and methods for evaluating their biopersistence. In addition, at the end of this article, we note some of the gaps in our knowledge and make recommendations for future research.
Fiber biopersistence can be defined as the retention in the lung, over time, of fibers with regard to number, dimension, surface chemistry, chemical composition, surface area, and similar physical characteristics. Changes in any of these parameters may alter fiber toxicity. For this article, the term "lung" is used to encompass the respiratory airways, parenchyma, and the pleura. Earlier articles in this volume document the influence of fiber characteristics on toxicity and carcinogenicity, and cover in detail many of the points made here. A summary of a Workshop on Evaluating the Toxicity and Carcinogenicity of ManMade Fibers has also been published (1) .
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Fibers can be eliminated from the lung by bulk clearance, primarily involving macrophage uptake and transport to the mucociliary escalator, and by dissolution. Mechanisms for translocation of fibers to the pleura and the clearance of fibers from pleural spaces are not as well understood. In vivo fiber instillation experiments have demonstrated that short segments of manmade vitreous fibers (MMVF) are more readily removed from the lungs by macrophages and mucociliary dearance than longer fibers (2) . The same phenomenon has been demonstrated for chrysotile asbestos following inhalation (3) . It has also been shown that fibers can be cleared from terminal airways by epithelial cell uptake (3) , with subsequent translocation into the interstitium and lymphatic system (4, 5) .
Fiber biopersistence is dependent upon the site and rate of deposition, as well as on rates of translocation, clearance, dissolution, and biomodification of the fiber in the lung. It is quite possible that a change in the rate of one of these processes could affect the rates of other processes. For example, a large increase in the rate of deposition in the alveolar region could potentially overwhelm macrophage clearance mechanisms and increase the rate of translocation to the lung interstitium. A better understanding of the biological fate of a fiber in the lung, which is dependent upon all the various fiber characteristics, is critical to understanding the mechanisms underlying the differences in the toxic potential of man-made fibers of different compositions. Before focusing on biopersistence, it is useful to review the factors determining the deposition and biological fate of fibers in the lung.
Deposition
Fiber inhalation and deposition are the initial events in fiber-induced lung disease. Fiber size and geometry are the determinants of both host entry and intrapulmonic distribution, and the essential determinant of host entry is the aerodynamic diameter of the fiber (6) . Fibers having aerodynamic diameters greater than 12 pm for humans and 6 pm for rodents are not likely to reach the bronchioles and alveoli ( 7) . Fibers with diameters less than or equal to 3 pm are considered respirable, even those with lengths as great as 100 to 200 pm (8, 9) . This is because the role of fiber diameter, rather than length, is dominant in determining aerodynamic diameter.
Fibers deposit mainly by impaction, sedimentation, and interception; very little is known about the role of electrostatic precipitation and diffusion in the deposition of fibers (10) . Both impaction and sedimentation are governed by the aerodynamic diameter of the fibers. Impaction is favored by high airflow velocities and is the predominant mechanism for fiber deposiEnvironmental Health Perspectives tion in large airways. In contrast, sedimentation is favored by low flow velocity, long residence time, and small airway size. The role of interception increases with fiber length (8) .
Some authors have developed correlations for the risk of lung cancer associated with surface area, dimensions, and number of asbestos fibers in the lung, since these are the generally accepted determinants of biopersistence (11) 
Dissolution
Evidence of in vivo dissolution of MMVF in the lungs has been extensively reviewed (14, 15) . It has been demonstrated that the dissolution of inhaled MMVF is dependent on fiber length, which may be due to differences in extracellular and intracellular pH and to the chemical composition of the fibers (16, 17 
Chronic Inhalation Studies
Relatively few long-term inhalation studies with either naturally occurring or manmade fibers have been conducted (1) . Fortunately, new technology for conducting such exposures, as described elsewhere (22) (23) (24) , provides the opportunity to conduct inhalation studies that meet standards previously not attainable. In one chronic inhalation study, the biological effects on rats of long-term exposure to glass fibers (FG) (23) were compared with the effects of exposure to chrysotile asbestos and to RCF (25) . The glass fibers, which were of similar composition to common building insulation wools, produced no lung fibrosis in the exposed rats even after 24 months at a concentration of 30 mg/m3, neither were there any mesotheliomas nor any significant increase in lung tumors. In contrast, exposure to chrysotile and, to a lesser extent, to RCF, resulted in lung fibrosis, mesotheliomas, and a significant increase in lung tumors.
These findings are significant because observed lung burdens and dimensions of FG were comparable to those of RCF 1-exposed animals, yet FG did not induce lung fibrosis or tumors. This suggests that internal dose and dimension are not sufficient to explain the toxic potential of two chemically different types of fibers. Chemical composition and surface physicochemical properties also may be important determinants of fiber toxicity for similarly sized fibers. The importance of other fiber characteristics, such as chemical composition, surface charge, and biological persistence as determinants of fiber toxicity is now well recognized (1, 15, 20, 22) .
Methodological Issues
It is important to consider methodological issues related to the administration of the test material and to the recovery of fibers from lung tissue to study the lung burden, biopersistence, and toxicity of fibers. Although intratracheal instillation permits precise dosage and is economical, the suitability of this model for fiber toxicity evaluation is still debatable. Distribution and deposition patterns within the lung airways after intratracheal instillation may not be the same as after inhalation. For example, intratracheal instillation of suspended fibers can result in granulomas containing fibers in the upper airways (bolus effect), although this was overcome by using fiber suspensions at low concentrations (18) . Validation by a comparison of instillation and inhalation studies is certainly necessary, and intracavitary administration of fibers should also be included in the comparisons.
The low durability of MMVF in comparison to asbestos poses special problems in the storage of exposed lung tissue and subsequent fiber recovery. Storage in a fixative of tissue containing MMVF can alter the chemical composition of the fiber (26) , as can some wet tissue digestion techniques, which can also alter physical dimensions of fibers (27) Figure 2 Interrelationship among information acquired from epidemiological studies of asbestos-exposed people, laboratory studies for asbestos, and man-made fibers and estimated human risk from man-made fibers.
would be a complete understanding of how inhaled fibers cause disease and the identification of all necessary and sufficient steps, including those relating to biopersistence. With that level of knowledge, it would then be possible to develop procedures to evaluate the potential of any fiber to initiate any of those steps. Unfortunately, our present knowledge of the mechanisms by which fibers cause disease is incomplete; moreover, it has emerged primarily from studies of asbestosexposed people and laboratory studies with various kinds of asbestos and man-made fibers (Figure 1 ). Our confidence in this schematic model as a descriptor for asbestos is greatly strengthened by actual observations of human disease as the endpoints of concern-pleural and lung fibrosis, bronchogenic carcinomas and mesotheliomas. Similar diseases have been observed in asbestos-exposed laboratory animals, which, in a sense, validates the laboratory animal model. A paradigm for extending our knowledge to man-made fibers is shown in Figure 2 . The aim is to study man-made fibers and apply the knowledge gained early enough to establish appropriate control procedures that would prevent fiber-induced disease in people and so, fortunately, limit the potential for observing the effects on humans.
The development of more structured exposure-dose-response models is most necessary (Figure 3) It is generally agreed that the greater the durability of a fiber type, the greater is its likelihood of causing disease. Conversely, the lower the durability, the lower is the disease-causing potential, so that fibers that dissolve relatively rapidly should have lower potential for causing disease.
In a test of an experimental fiber of moderately high solubility by intracavitary instillation in rats, tumors were observed only at very high dose level (30) . Interpretation of this result must take into account the mode of administration as well as the dose administered, but would suggest that even soluble fibers might be carcinogenic if the fiber dose were high enough. Special care is required in making such an interpretation based on a single, and perhaps overly simplified, procedure.
These considerations also point to the need to shift our orientation from asking whether the material is carcinogenic to asking what is the potential cancer risk at anticipated levels of human exposure. This kind of orientation is inherent in the use of exposure-response models (Figure 3 ). It also requires careful consideration of likely human exposure circumstances throughout the product life cycle (Figure 6 
Future Research Needs Generic Reseah
The most critical research needs are for the acquisition of information that will provide mechanistic linkages between exposure and dose, and between dose and response ( Figure 3 ). To be most useful, this should include information acquired from studies conducted at multiple exposure levels and durations, so that convincing evidence may be obtained as to the likely mechanisms of action at relevant potential human exposure levels.
There is, first of all, need for improved techniques for characterizing fiber exposures, including both potential human exposure circumstances within a product life cycle and experimental exposures ( Figure 6 ). It will be especially useful to develop techniques to characterize fibers not only by their dimensions, as has been traditional, but also by surface area and chemistry, which may have special toxicological relevance.
Second, there is a critical need for improved information on the disposition of inhaled fibers both in laboratory animals and humans. Much of our current understanding has been derived indirectly from a much more abundant knowledge base relating to inhaled particles. The techniques are now at hand to develop a similar body of experimental data on the influence of fiber diameter and length on initial deposition and clearance of fibers. Such data are needed on the more frequently used laboratory animal species and, ideally, on people, to enhance our ability to make extrapolations from laboratory animals ( Figure 2 ). The emerging technology should make it possible to obtain much more detailed knowledge on the clearance of fibers of varied size and chemical composition, and to develop models of the regional fate of fibers in the lung and the relative role of physical removal and of dissolution. Once the models have been validated, it will be possible to consider "dose terms" that move beyond the total lung to specific regional tissues Figure 4 , test fibers A and B). Studying the various steps in the underlying biological processes and how they relate to the physical and chemical characteristics of the fibers will help us to understand which of these characteristics are essential to the carcinogenesis process.
The prospects for progress will be further enhanced as more man-made fibers are evaluated in life-span in vivo bioassays, of comparable quality to those recently conducted, and in which it will be especially important to understand as completely as possible the full exposuredose-response paradigm. In addition to studies with man-made fibers, animal lifespan-bioassay studies with asbestos fibers of different types using contemporary inhalation exposure technology and methods will be of unique value. They would provide a linkage to the data base acquired from epidemiological studies of asbestosexposed populations (Figures 2,4) . With these approaches, it should be possible in the not-too-distant future to identify characteristics of biopersistence linked to the carcinogenicity of fibers that would be evaluated in short-to-intermediate-term studies and so could serve as indicators of the carcinogenic potential of newly developed fibers. The degree of confidence in these indicators will depend on the extent to which the assay systems have been validated by comparing fibers that produce cancer with those that do not.
